Bronchoscopic management of bronchopleural fistula
Journal Title: Current Thoracic Surgery - Year 2016, Vol 1, Issue 1
Abstract
Bronchopleural fistula (BPF) represents a pathological communication between any part of bronchial tree and the pleural space. Mostly it is a rare yet serious complication of different pulmonary conditions like certain infections, trauma, malignancy and/or surgery, going along with significant mortality reported to be as high as 58%. Diagnosis of BPF is mostly done by evaluating these three data: clinical appearance, bronchoscopy and CT scan. The treatment of BPF may initially differ according to the time of appearance as well as clinical presentation. As most BPF goes along with empyema, it is, obviously, necessary to deal with it. This is most commonly achieved with a chest tube. Conservative management of BPF can be achieved using a significant variety of materials and methods with reportedly moderate to excellent results in the treatment of etiologically and sizably different BPF. Methyl-2-cyanoacrylate, fibrin sealant together with spongy calf bone, polidocanol - hydroxypolyethoxidodecane, amplatzer device, silver nitrate, stenting and endobronchial valves have all been employed in bronchoscopic treatment of a BPF. There is no evidence based guideline for its management, either surgically or endoscopically. The treatment of choice is always in the hands of the physician, preferably armed with the current knowledge and capacity of utilizing it.
Authors and Affiliations
Davor Stamenovica
Keywords
Related Articles
- EP ID EP288935
- DOI 10.26663/cts.2016.0009
- Views 69
- Downloads 0
Intraoperative findings of spontaneous hemopneumothorax
Intraoperative findings of spontaneous hemopneumothorax
Granulomatous disease in patients operated due to provisional diagnosis of lung cancer
Background: The granulomatous reaction is a response that can occur in many infective, toxic, allergic, autoimmune, neoplastic, and etiologically unknown conditions. Hundreds of different agents that can cause this respo...
Upregulated mRNA expression of mTOR in surgically resected early stage non-small cell lung carcinoma: a potential molecular targeted therapy
Background: Non-small cell lung cancer (NSCLC) comprises about 85% of all lung cancers. Although many attempts for early detection and treatment, prognosis of NSCLC is still poor. In recent years the pathways and the ge...
Atypical pulmonary hydatidosis lesions mimicking other lung lesions
Background: Hydatid cyst disease, which is mostly caused by Echinococcus granulosus, may result in high morbidity rates particularly in endemic regions, and mortality depending on its size and on the organs where it is l...
Comparison of the outcomes of the implanted subcutaneous ports in cancer patients: six-years single center experience
Background: The preferred site of venous access ranges from deep veins (internal jugular or subclavian veins) to superficial veins (external jugular, anterior jugular, and upper limb veins). The aim of the study is to e...